speb/financial-data huggingface dataset:
FRST income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 2156000.00
FRST income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 472000.00
FRST income_statement (annual, 2025-12-31) — Selling General And Administration: 84946000.00
FRST income_statement (quarterly, 2025-12-31) — Selling General And Administration: 26925000.00
FRST balance_sheet (annual, 2025-12-31) — Share Issued: 24774934.00
FRST balance_sheet (quarterly, 2025-12-31) — Share Issued: 24774934.00
FRST cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 25000000.00
FRST cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: -60000000.00
FRST cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
FRST income_statement (annual, 2025-12-31) — Special Income Charges: 82492000.00
FRST income_statement (quarterly, 2025-12-31) — Special Income Charges: 50170000.00
FRST cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2904000.00
FRST cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2843000.00
FRST balance_sheet (annual, 2025-12-31) — Stockholders Equity: 422896000.00
FRST balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 422896000.00
FRST balance_sheet (annual, 2025-12-31) — Tangible Book Value: 324162000.00
FRST balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 324162000.00
FRST income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 16728296.11
FRST income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 9303550.26
FRST income_statement (annual, 2025-12-31) — Tax Provision: 14713000.00
FRST income_statement (quarterly, 2025-12-31) — Tax Provision: 6725000.00
FRST income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
FRST income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.19
FRST balance_sheet (annual, 2025-12-31) — Total Assets: 4047388000.00
FRST balance_sheet (quarterly, 2025-12-31) — Total Assets: 4047388000.00
FRST balance_sheet (annual, 2025-12-31) — Total Capitalization: 558831000.00
FRST balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 558831000.00
FRST balance_sheet (annual, 2025-12-31) — Total Debt: 197275000.00
FRST balance_sheet (quarterly, 2025-12-31) — Total Debt: 197275000.00
FRST balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 422896000.00
FRST balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 422896000.00
FRST balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3624492000.00
FRST balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3624492000.00
FRST income_statement (annual, 2025-12-31) — Total Unusual Items: 82492000.00
FRST income_statement (quarterly, 2025-12-31) — Total Unusual Items: 50170000.00
FRST income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 82492000.00
FRST income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 50170000.00
FRST balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 79549.00
FRST balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 79549.00
FRST balance_sheet (annual, 2025-12-31) — Treasury Stock: 807000.00
FRST balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 807000.00
FRST income_statement (quarterly, 2026-03-31) — +Total Revenue: 45629000.00
FRST balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 19830000.00
FRST balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 316840000.00
FRST balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 11396000.00
FRST income_statement (quarterly, 2026-03-31) — Basic Average Shares: 24665011.00
FRST income_statement (quarterly, 2026-03-31) — Basic EPS: 0.33
FRST cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 143607000.00
FRST cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -204000.00
FRST balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 60832000.00
FRST balance_sheet (quarterly, 2026-03-31) — Capital Stock: 248000.00
FRST balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 159881000.00
FRST balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 159881000.00
FRST cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -2559000.00
FRST balance_sheet (quarterly, 2026-03-31) — Cash Financial: 8360000.00
FRST cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 202684000.00
FRST cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -132048000.00
FRST cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -54362000.00
FRST cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -8642000.00
FRST cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -195000.00
FRST cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -8837000.00
FRST cash_flow (quarterly, 2026-03-31) — Changes In Cash: 16274000.00
FRST balance_sheet (quarterly, 2026-03-31) — Common Stock: 248000.00
FRST cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -2559000.00
FRST balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 427198000.00
FRST cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 298000.00
FRST cash_flow (quarterly, 2026-03-31) — Deferred Tax: 298000.00
FRST cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3395000.00
FRST cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3395000.00
FRST income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 24719255.00
FRST income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.33
FRST income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 7312000.00
FRST cash_flow (quarterly, 2026-03-31) — End Cash Position: 159881000.00
FRST cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 202684000.00
FRST cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -54566000.00
FRST cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: 0.00
FRST cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
FRST income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 396000.00
FRST balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -3453000.00
FRST income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 20294000.00
FRST balance_sheet (quarterly, 2026-03-31) — Goodwill: 93459000.00
FRST balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 97919000.00
FRST balance_sheet (quarterly, 2026-03-31) — Gross PPE: 70705000.00
FRST balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 6792000.00
FRST cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 524000.00
FRST income_statement (quarterly, 2026-03-31) — Insurance And Claims: 738000.00
FRST income_statement (quarterly, 2026-03-31) — Interest Expense: 21452000.00
FRST income_statement (quarterly, 2026-03-31) — Interest Income: 53526000.00
FRST cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 21127000.00
FRST balance_sheet (quarterly, 2026-03-31) — Invested Capital: 740959000.00
FRST cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -132048000.00
FRST balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 185568000.00
FRST cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 205000000.00
FRST balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 60832000.00
FRST balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 313761000.00
FRST balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 374593000.00
FRST cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 205000000.00
FRST cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -27323000.00
FRST balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 6899000.00
FRST income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
FRST balance_sheet (quarterly, 2026-03-31) — Net Debt: 153880000.00
FRST income_statement (quarterly, 2026-03-31) — Net Income: 7312000.00
FRST income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 7312000.00
FRST income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 7312000.00
FRST income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 7312000.00
FRST income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 7312000.00
FRST cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 7312000.00
FRST income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 7312000.00
FRST income_statement (quarterly, 2026-03-31) — Net Interest Income: 32074000.00
FRST cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -1230000.00
FRST cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 177677000.00
FRST cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 177677000.00
FRST cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -17493000.00
FRST balance_sheet (quarterly, 2026-03-31) — Net PPE: 70705000.00
FRST cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -204000.00
FRST balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 329279000.00
FRST income_statement (quarterly, 2026-03-31) — Normalized Income: 7312000.00
FRST income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 4617000.00
FRST cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -54362000.00
FRST cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -11327000.00
FRST income_statement (quarterly, 2026-03-31) — Operating Revenue: 45629000.00
FRST balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 24772072.00
FRST balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -3453000.00
FRST balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 4460000.00
FRST cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -46827000.00
FRST income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 6223000.00
FRST balance_sheet (quarterly, 2026-03-31) — Other Properties: 70705000.00
FRST balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 160481000.00
FRST balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
FRST income_statement (quarterly, 2026-03-31) — Pretax Income: 10326000.00
FRST cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 113000.00
FRST income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 1860000.00
FRST cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -8265000.00
FRST cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -204000.00
FRST balance_sheet (quarterly, 2026-03-31) — Receivables: 19830000.00
FRST income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3395000.00
FRST cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -27323000.00
FRST balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 114370000.00
FRST income_statement (quarterly, 2026-03-31) — Salaries And Wages: 19556000.00
FRST cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 7035000.00
FRST income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 760000.00
FRST income_statement (quarterly, 2026-03-31) — Selling General And Administration: 21054000.00
FRST balance_sheet (quarterly, 2026-03-31) — Share Issued: 24851621.00
FRST income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
FRST cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 113000.00
FRST balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 427198000.00
FRST balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 329279000.00
FRST income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
FRST income_statement (quarterly, 2026-03-31) — Tax Provision: 3014000.00
FRST income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
FRST balance_sheet (quarterly, 2026-03-31) — Total Assets: 4256668000.00
FRST balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 740959000.00
FRST balance_sheet (quarterly, 2026-03-31) — Total Debt: 374593000.00
FRST balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 427198000.00
FRST balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3829470000.00
FRST income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
FRST income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
FRST balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 79549.00
FRST balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 807000.00
FRST income_statement (quarterly, 2026-06-30) — Basic Average Shares: 24731956.00
FRST income_statement (quarterly, 2026-06-30) — Basic EPS: 0.38
FRST income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 24788023.00
FRST income_statement (quarterly, 2026-06-30) — Diluted EPS: 0.38
FRSX balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 4011000.00
FRSX income_statement (annual, 2021-12-31) — Earnings From Equity Interest: 0.00
FRSX cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: 0.00
FRSX balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 4011000.00
FRSX balance_sheet (annual, 2021-12-31) — Investments And Advances: 4011000.00
FRSX cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
FRSX balance_sheet (annual, 2021-12-31) — Other Current Assets: 1000.00
FRSX balance_sheet (annual, 2021-12-31) — Other Payable: 445000.00
FRSX cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 652000.00
FRSX cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
FRSX cash_flow (annual, 2021-12-31) — Purchase Of Investment: -12347000.00
FRSX income_statement (annual, 2022-12-31) — +Operating Expense: 17753000.00
FRSX income_statement (annual, 2022-12-31) — +Total Revenue: 550000.00
FRSX balance_sheet (annual, 2022-12-31) — Accounts Payable: 315000.00
FRSX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 0.00
FRSX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1076000.00
FRSX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 129810000.00
FRSX balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 2804000.00
FRSX income_statement (annual, 2022-12-31) — Basic Average Shares: 512666.00
FRSX income_statement (annual, 2022-12-31) — Basic EPS: -42.28
FRSX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 28188000.00
FRSX cash_flow (annual, 2022-12-31) — Capital Expenditure: -313000.00
FRSX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 2003000.00
FRSX balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
FRSX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 19173000.00
FRSX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 26391000.00
FRSX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 0.00
FRSX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 8983000.00
FRSX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -17057000.00
FRSX cash_flow (annual, 2022-12-31) — Change In Account Payable: 62000.00
FRSX cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -182000.00
FRSX cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -289000.00
FRSX cash_flow (annual, 2022-12-31) — Change In Payable: -10000.00
FRSX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -10000.00
FRSX cash_flow (annual, 2022-12-31) — Change In Receivables: 0.00
FRSX cash_flow (annual, 2022-12-31) — Change In Working Capital: -481000.00
FRSX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 0.00
FRSX cash_flow (annual, 2022-12-31) — Changes In Cash: -8074000.00
FRSX balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
FRSX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 28330000.00
FRSX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
FRSX income_statement (annual, 2022-12-31) — Cost Of Revenue: 252000.00
FRSX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 299000.00
FRSX balance_sheet (annual, 2022-12-31) — Current Assets: 27335000.00
FRSX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 527000.00
FRSX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 527000.00
FRSX balance_sheet (annual, 2022-12-31) — Current Liabilities: 2634000.00
FRSX cash_flow (annual, 2022-12-31) — Depreciation: 218000.00
FRSX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 218000.00
FRSX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 218000.00
FRSX income_statement (annual, 2022-12-31) — Diluted Average Shares: 512666.00
FRSX income_statement (annual, 2022-12-31) — Diluted EPS: -42.28
FRSX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -21676000.00
FRSX income_statement (annual, 2022-12-31) — EBIT: -17455000.00
FRSX income_statement (annual, 2022-12-31) — EBITDA: -17237000.00
FRSX income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 0.00
FRSX cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 0.00
FRSX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -839000.00
FRSX cash_flow (annual, 2022-12-31) — End Cash Position: 19275000.00
FRSX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 0.00
FRSX cash_flow (annual, 2022-12-31) — Free Cash Flow: -17370000.00
FRSX income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -4402000.00
FRSX income_statement (annual, 2022-12-31) — General And Administrative Expense: 5865000.00
FRSX balance_sheet (annual, 2022-12-31) — Gross PPE: 3830000.00
FRSX income_statement (annual, 2022-12-31) — Gross Profit: 298000.00
FRSX income_statement (annual, 2022-12-31) — Interest Income: 189000.00
FRSX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 189000.00
FRSX balance_sheet (annual, 2022-12-31) — Invested Capital: 28330000.00
FRSX cash_flow (annual, 2022-12-31) — Investing Cash Flow: 8983000.00
FRSX balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 2804000.00
FRSX balance_sheet (annual, 2022-12-31) — Investments And Advances: 2804000.00
FRSX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
FRSX balance_sheet (annual, 2022-12-31) — Leases: 479000.00
FRSX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1476000.00
FRSX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1476000.00
FRSX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1195000.00
FRSX balance_sheet (annual, 2022-12-31) — Minority Interest: 453000.00
FRSX cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -715000.00
FRSX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
FRSX cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 839000.00
FRSX income_statement (annual, 2022-12-31) — Net Income: -21676000.00
FRSX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -21676000.00
FRSX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -21676000.00
FRSX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -21676000.00
FRSX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -21676000.00
FRSX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -21676000.00
FRSX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -21676000.00
FRSX income_statement (annual, 2022-12-31) — Net Interest Income: 181000.00
FRSX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 9296000.00
FRSX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 181000.00
FRSX balance_sheet (annual, 2022-12-31) — Net PPE: 2754000.00
FRSX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -313000.00
FRSX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 28330000.00
FRSX income_statement (annual, 2022-12-31) — Normalized EBITDA: -12835000.00
FRSX income_statement (annual, 2022-12-31) — Normalized Income: -17274000.00
FRSX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -17057000.00
FRSX cash_flow (annual, 2022-12-31) — Operating Gains Losses: 839000.00
FRSX income_statement (annual, 2022-12-31) — Operating Income: -17455000.00
FRSX income_statement (annual, 2022-12-31) — Operating Revenue: 550000.00
FRSX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 46139936.00
FRSX income_statement (annual, 2022-12-31) — Other Gand A: 1996000.00
FRSX income_statement (annual, 2022-12-31) — Other Income Expense: -4402000.00
FRSX balance_sheet (annual, 2022-12-31) — Other Properties: 2156000.00
FRSX balance_sheet (annual, 2022-12-31) — Other Receivables: 462000.00
FRSX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 7218000.00
FRSX balance_sheet (annual, 2022-12-31) — Payables: 315000.00
FRSX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 614000.00
FRSX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1493000.00
FRSX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 380000.00
FRSX income_statement (annual, 2022-12-31) — Pretax Income: -21676000.00
FRSX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
FRSX balance_sheet (annual, 2022-12-31) — Properties: 0.00
FRSX cash_flow (annual, 2022-12-31) — Purchase Of Business: -715000.00
FRSX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -1001000.00
FRSX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -313000.00
FRSX balance_sheet (annual, 2022-12-31) — Receivables: 462000.00
FRSX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 252000.00
FRSX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 218000.00
FRSX income_statement (annual, 2022-12-31) — Rent And Landing Fees: 175000.00
FRSX income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 175000.00
FRSX income_statement (annual, 2022-12-31) — Research And Development: 11534000.00
FRSX balance_sheet (annual, 2022-12-31) — Restricted Cash: 102000.00
FRSX balance_sheet (annual, 2022-12-31) — Retained Earnings: -101480000.00
FRSX income_statement (annual, 2022-12-31) — Salaries And Wages: 3694000.00
FRSX cash_flow (annual, 2022-12-31) — Sale Of Investment: 10297000.00
FRSX income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 354000.00
FRSX income_statement (annual, 2022-12-31) — Selling General And Administration: 6219000.00
FRSX balance_sheet (annual, 2022-12-31) — Share Issued: 46139936.00
FRSX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1826000.00
FRSX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 28330000.00
FRSX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 28330000.00
FRSX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
FRSX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
FRSX balance_sheet (annual, 2022-12-31) — Total Assets: 32893000.00
FRSX balance_sheet (annual, 2022-12-31) — Total Capitalization: 28330000.00
FRSX balance_sheet (annual, 2022-12-31) — Total Debt: 2003000.00
FRSX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 28783000.00
FRSX income_statement (annual, 2022-12-31) — Total Expenses: 18005000.00
FRSX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4110000.00
FRSX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 5558000.00
FRSX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1476000.00
FRSX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -17455000.00
FRSX income_statement (annual, 2022-12-31) — Total Other Finance Cost: 8000.00
FRSX income_statement (annual, 2022-12-31) — Total Unusual Items: -4402000.00
FRSX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -4402000.00
FRSX cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 2217000.00
FRSX balance_sheet (annual, 2022-12-31) — Working Capital: 24701000.00
FRSX income_statement (annual, 2023-12-31) — +Operating Expense: 16645000.00
FRSX income_statement (annual, 2023-12-31) — +Total Revenue: 497000.00
FRSX balance_sheet (annual, 2023-12-31) — Accounts Payable: 136000.00
FRSX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 308000.00
FRSX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1317000.00
FRSX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 135282000.00
FRSX income_statement (annual, 2023-12-31) — Basic Average Shares: 3681689.00
FRSX income_statement (annual, 2023-12-31) — Basic EPS: -5.40
FRSX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 19275000.00
FRSX cash_flow (annual, 2023-12-31) — Capital Expenditure: -124000.00
FRSX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1631000.00
FRSX balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
FRSX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 15635000.00
FRSX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 16109000.00
FRSX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 4181000.00
FRSX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 7092000.00
FRSX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -14926000.00
FRSX cash_flow (annual, 2023-12-31) — Change In Account Payable: -179000.00
FRSX cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 311000.00
FRSX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -18000.00
FRSX cash_flow (annual, 2023-12-31) — Change In Payable: -423000.00
FRSX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -423000.00
FRSX cash_flow (annual, 2023-12-31) — Change In Receivables: -308000.00
FRSX cash_flow (annual, 2023-12-31) — Change In Working Capital: -438000.00
FRSX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -308000.00
FRSX cash_flow (annual, 2023-12-31) — Changes In Cash: -3653000.00
FRSX balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
FRSX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 15392000.00
FRSX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 4181000.00
FRSX income_statement (annual, 2023-12-31) — Cost Of Revenue: 143000.00
FRSX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 163000.00
FRSX balance_sheet (annual, 2023-12-31) — Current Assets: 17047000.00
FRSX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 468000.00
FRSX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 468000.00
FRSX balance_sheet (annual, 2023-12-31) — Current Liabilities: 2152000.00
FRSX cash_flow (annual, 2023-12-31) — Depreciation: 263000.00
FRSX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 263000.00
FRSX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 263000.00
FRSX income_statement (annual, 2023-12-31) — Diluted Average Shares: 3681689.00
FRSX income_statement (annual, 2023-12-31) — Diluted EPS: -5.40
FRSX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -18410000.00
FRSX income_statement (annual, 2023-12-31) — EBIT: -16291000.00
FRSX income_statement (annual, 2023-12-31) — EBITDA: -16028000.00
FRSX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 112000.00
FRSX cash_flow (annual, 2023-12-31) — End Cash Position: 15734000.00
FRSX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 4181000.00
FRSX cash_flow (annual, 2023-12-31) — Free Cash Flow: -15050000.00
FRSX income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -2776000.00
FRSX income_statement (annual, 2023-12-31) — General And Administrative Expense: 4611000.00
FRSX balance_sheet (annual, 2023-12-31) — Gross PPE: 3580000.00
FRSX income_statement (annual, 2023-12-31) — Gross Profit: 354000.00
FRSX income_statement (annual, 2023-12-31) — Interest Income: 667000.00
FRSX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 667000.00
FRSX balance_sheet (annual, 2023-12-31) — Invested Capital: 15392000.00
FRSX cash_flow (annual, 2023-12-31) — Investing Cash Flow: 7092000.00
FRSX balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 0.00
FRSX balance_sheet (annual, 2023-12-31) — Investments And Advances: 0.00
FRSX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 4181000.00
FRSX balance_sheet (annual, 2023-12-31) — Leases: 488000.00
FRSX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1163000.00
FRSX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1163000.00
FRSX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1290000.00
FRSX balance_sheet (annual, 2023-12-31) — Minority Interest: 603000.00
FRSX cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
FRSX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 4181000.00
FRSX cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -112000.00
FRSX income_statement (annual, 2023-12-31) — Net Income: -18410000.00
FRSX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -18410000.00
FRSX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -18410000.00
FRSX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -18410000.00
FRSX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -18410000.00
FRSX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -18410000.00
FRSX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -18410000.00
FRSX income_statement (annual, 2023-12-31) — Net Interest Income: 657000.00
FRSX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 7216000.00
FRSX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 657000.00
FRSX balance_sheet (annual, 2023-12-31) — Net PPE: 2263000.00
FRSX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -124000.00
FRSX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 15392000.00
FRSX income_statement (annual, 2023-12-31) — Normalized EBITDA: -13252000.00
FRSX income_statement (annual, 2023-12-31) — Normalized Income: -15634000.00
FRSX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -14926000.00
FRSX cash_flow (annual, 2023-12-31) — Operating Gains Losses: -112000.00
FRSX income_statement (annual, 2023-12-31) — Operating Income: -16291000.00
FRSX income_statement (annual, 2023-12-31) — Operating Revenue: 497000.00
FRSX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 65682579.00
FRSX income_statement (annual, 2023-12-31) — Other Gand A: 1421000.00
FRSX income_statement (annual, 2023-12-31) — Other Income Expense: -2776000.00
FRSX balance_sheet (annual, 2023-12-31) — Other Properties: 1802000.00
FRSX balance_sheet (annual, 2023-12-31) — Other Receivables: 384000.00
FRSX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 474000.00
FRSX balance_sheet (annual, 2023-12-31) — Payables: 136000.00
FRSX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 299000.00
FRSX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1385000.00
FRSX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 147000.00
FRSX income_statement (annual, 2023-12-31) — Pretax Income: -18410000.00
FRSX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
FRSX balance_sheet (annual, 2023-12-31) — Properties: 0.00
FRSX cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
FRSX cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
FRSX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -124000.00
FRSX balance_sheet (annual, 2023-12-31) — Receivables: 692000.00
FRSX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 143000.00
FRSX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 263000.00
FRSX income_statement (annual, 2023-12-31) — Rent And Landing Fees: 196000.00
FRSX income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 196000.00
FRSX income_statement (annual, 2023-12-31) — Research And Development: 11587000.00
FRSX balance_sheet (annual, 2023-12-31) — Restricted Cash: 99000.00
FRSX balance_sheet (annual, 2023-12-31) — Retained Earnings: -119890000.00
FRSX income_statement (annual, 2023-12-31) — Salaries And Wages: 2994000.00
FRSX cash_flow (annual, 2023-12-31) — Sale Of Investment: 7216000.00
FRSX income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 447000.00
FRSX income_statement (annual, 2023-12-31) — Selling General And Administration: 5058000.00
FRSX balance_sheet (annual, 2023-12-31) — Share Issued: 65682579.00
FRSX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1441000.00
FRSX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 15392000.00
FRSX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 15392000.00
FRSX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
FRSX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
FRSX balance_sheet (annual, 2023-12-31) — Total Assets: 19310000.00
FRSX balance_sheet (annual, 2023-12-31) — Total Capitalization: 15392000.00
FRSX balance_sheet (annual, 2023-12-31) — Total Debt: 1631000.00
FRSX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 15995000.00
FRSX income_statement (annual, 2023-12-31) — Total Expenses: 16788000.00
FRSX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3315000.00
FRSX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2263000.00
FRSX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1163000.00
FRSX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -16291000.00
FRSX income_statement (annual, 2023-12-31) — Total Other Finance Cost: 10000.00
FRSX income_statement (annual, 2023-12-31) — Total Unusual Items: -2776000.00
FRSX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -2776000.00
FRSX cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 2330000.00
FRSX balance_sheet (annual, 2023-12-31) — Working Capital: 14895000.00
FRSX income_statement (quarterly, 2024-09-30) — +Operating Expense: 3426000.00
FRSX income_statement (quarterly, 2024-09-30) — +Total Revenue: 111000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 281000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 430000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 135858000.00
FRSX income_statement (quarterly, 2024-09-30) — Basic Average Shares: 729806.00
FRSX income_statement (quarterly, 2024-09-30) — Basic EPS: -4.56
FRSX cash_flow (quarterly, 2024-09-30) — Beginning Cash Position: 12064000.00
FRSX cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -23000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 1634000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Capital Stock: 0.00
FRSX balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 8840000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 8855000.00
FRSX cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Financing Activities: 143000.00
FRSX cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Investing Activities: -23000.00
FRSX cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Operating Activities: -3309000.00
FRSX cash_flow (quarterly, 2024-09-30) — Change In Account Payable: 41000.00
FRSX cash_flow (quarterly, 2024-09-30) — Change In Other Current Liabilities: 106000.00
FRSX cash_flow (quarterly, 2024-09-30) — Change In Payable: 39000.00
FRSX cash_flow (quarterly, 2024-09-30) — Change In Payables And Accrued Expense: 39000.00
FRSX cash_flow (quarterly, 2024-09-30) — Change In Receivables: -362000.00
FRSX cash_flow (quarterly, 2024-09-30) — Change In Working Capital: -217000.00
FRSX cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: -219000.00
FRSX cash_flow (quarterly, 2024-09-30) — Changes In Cash: -3189000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Common Stock: 0.00
FRSX balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 7930000.00
FRSX cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 143000.00
FRSX income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 76000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Current Assets: 10026000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 314000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 314000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 2174000.00
FRSX cash_flow (quarterly, 2024-09-30) — Depreciation: 44000.00
FRSX cash_flow (quarterly, 2024-09-30) — Depreciation Amortization Depletion: 44000.00
FRSX cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 44000.00
FRSX income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 729806.00
FRSX income_statement (quarterly, 2024-09-30) — Diluted EPS: -4.56
FRSX income_statement (quarterly, 2024-09-30) — Diluted NI Availto Com Stockholders: -3330000.00
FRSX income_statement (quarterly, 2024-09-30) — EBIT: -3391000.00
FRSX income_statement (quarterly, 2024-09-30) — EBITDA: -3347000.00
FRSX cash_flow (quarterly, 2024-09-30) — Effect Of Exchange Rate Changes: 63000.00
FRSX cash_flow (quarterly, 2024-09-30) — End Cash Position: 8938000.00
FRSX cash_flow (quarterly, 2024-09-30) — Financing Cash Flow: 143000.00
FRSX cash_flow (quarterly, 2024-09-30) — Free Cash Flow: -3332000.00
FRSX income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 746000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Gross PPE: 2046000.00
FRSX income_statement (quarterly, 2024-09-30) — Gross Profit: 35000.00
FRSX income_statement (quarterly, 2024-09-30) — Interest Income: 61000.00
FRSX income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 61000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Invested Capital: 7930000.00
FRSX cash_flow (quarterly, 2024-09-30) — Investing Cash Flow: -23000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 0.00
FRSX balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 0.00
FRSX cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 143000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 1320000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1320000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Minority Interest: 648000.00
FRSX cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 143000.00
FRSX cash_flow (quarterly, 2024-09-30) — Net Foreign Currency Exchange Gain Loss: -63000.00
FRSX income_statement (quarterly, 2024-09-30) — Net Income: -3330000.00
FRSX income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: -3330000.00
FRSX income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: -3330000.00
FRSX income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -3330000.00
FRSX income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -3330000.00
FRSX cash_flow (quarterly, 2024-09-30) — Net Income From Continuing Operations: -3330000.00
FRSX income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: -3330000.00
FRSX income_statement (quarterly, 2024-09-30) — Net Interest Income: 61000.00
FRSX cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 0.00
FRSX income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: 61000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Net PPE: 2046000.00
FRSX cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: -23000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 7930000.00
FRSX income_statement (quarterly, 2024-09-30) — Normalized EBITDA: -3347000.00
FRSX income_statement (quarterly, 2024-09-30) — Normalized Income: -3330000.00
FRSX cash_flow (quarterly, 2024-09-30) — Operating Cash Flow: -3309000.00
FRSX cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: -63000.00
FRSX income_statement (quarterly, 2024-09-30) — Operating Income: -3391000.00
FRSX income_statement (quarterly, 2024-09-30) — Operating Revenue: 111000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 65682579.00
FRSX income_statement (quarterly, 2024-09-30) — Other Gand A: 746000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Other Payable: 1579000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Other Properties: 2046000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Other Receivables: 643000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 15000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Payables: 1860000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Payables And Accrued Expenses: 1860000.00
FRSX income_statement (quarterly, 2024-09-30) — Pretax Income: -3330000.00
FRSX cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -23000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Receivables: 1073000.00
FRSX income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 76000.00
FRSX income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 44000.00
FRSX income_statement (quarterly, 2024-09-30) — Research And Development: 2442000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Restricted Cash: 98000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Retained Earnings: -127928000.00
FRSX cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
FRSX income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 238000.00
FRSX income_statement (quarterly, 2024-09-30) — Selling General And Administration: 984000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Share Issued: 65682579.00
FRSX cash_flow (quarterly, 2024-09-30) — Stock Based Compensation: 252000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 7930000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 7930000.00
FRSX income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
FRSX income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.00
FRSX balance_sheet (quarterly, 2024-09-30) — Total Assets: 12072000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 7930000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Total Debt: 1634000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 8578000.00
FRSX income_statement (quarterly, 2024-09-30) — Total Expenses: 3502000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 3494000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 2046000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1320000.00
FRSX income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: -3391000.00
FRSX cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: 5000.00
FRSX balance_sheet (quarterly, 2024-09-30) — Working Capital: 7852000.00
FRSX income_statement (annual, 2024-12-31) — +Operating Expense: 12940000.00
FRSX income_statement (quarterly, 2024-12-31) — +Operating Expense: 3252000.00
FRSX income_statement (annual, 2024-12-31) — +Total Revenue: 436000.00
FRSX income_statement (quarterly, 2024-12-31) — +Total Revenue: 101000.00
FRSX balance_sheet (annual, 2024-12-31) — Accounts Payable: 297000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 297000.00
FRSX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 113000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 113000.00
FRSX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1510000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1510000.00
FRSX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 137094000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 137094000.00
FRSX income_statement (annual, 2024-12-31) — Basic Average Shares: 807477.00
FRSX income_statement (quarterly, 2024-12-31) — Basic Average Shares: 807477.00
FRSX income_statement (annual, 2024-12-31) — Basic EPS: -13.79
FRSX income_statement (quarterly, 2024-12-31) — Basic EPS: -3.84
FRSX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 15734000.00
FRSX cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 8938000.00
FRSX cash_flow (annual, 2024-12-31) — Capital Expenditure: -62000.00
FRSX cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -7000.00
FRSX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1561000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 1561000.00
FRSX balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
FRSX balance_sheet (quarterly, 2024-12-31) — Capital Stock: 0.00
FRSX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 7082000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 7082000.00
FRSX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 7153000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 7153000.00
FRSX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 903000.00
FRSX cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 858000.00
FRSX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 1785000.00
FRSX cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -7000.00
FRSX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -11055000.00
FRSX cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -2620000.00
FRSX cash_flow (annual, 2024-12-31) — Change In Account Payable: 161000.00
FRSX cash_flow (quarterly, 2024-12-31) — Change In Account Payable: 16000.00
FRSX cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 51000.00
FRSX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 156000.00
FRSX cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: 33000.00
FRSX cash_flow (annual, 2024-12-31) — Change In Payable: -48000.00
FRSX cash_flow (quarterly, 2024-12-31) — Change In Payable: -264000.00
FRSX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -48000.00
FRSX cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -264000.00
FRSX cash_flow (annual, 2024-12-31) — Change In Receivables: 195000.00
FRSX cash_flow (quarterly, 2024-12-31) — Change In Receivables: 429000.00
FRSX cash_flow (annual, 2024-12-31) — Change In Working Capital: 354000.00
FRSX cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 249000.00
FRSX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 195000.00
FRSX cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 317000.00
FRSX cash_flow (annual, 2024-12-31) — Changes In Cash: -8367000.00
FRSX cash_flow (quarterly, 2024-12-31) — Changes In Cash: -1769000.00
FRSX balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
FRSX balance_sheet (quarterly, 2024-12-31) — Common Stock: 0.00
FRSX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 6066000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 6066000.00
FRSX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 903000.00
FRSX cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 858000.00
FRSX income_statement (annual, 2024-12-31) — Cost Of Revenue: 172000.00
FRSX income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 24000.00